Predictive Technology Group (Predictive Technology Group) Interest Expense : $-0.90 Mil (TTM As of Mar. 2021)

View and export this data going back to 2007. Start your Free Trial

What is Predictive Technology Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Predictive Technology Group's interest expense for the three months ended in Mar. 2021 was $ -0.47 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2021 was $-0.90 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Predictive Technology Group's Operating Income for the three months ended in Mar. 2021 was $ -3.23 Mil. Predictive Technology Group's Interest Expense for the three months ended in Mar. 2021 was $ -0.47 Mil. Predictive Technology Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Predictive Technology Group Interest Expense Historical Data

The historical data trend for Predictive Technology Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Technology Group Interest Expense Chart

Predictive Technology Group Annual Data

Trend

Aug06

Aug07

Jun16

Jun17

Jun18

Jun19

Jun20

Interest Expense

Get a 7-Day Free Trial

-0.02

-0.60

Predictive Technology Group Quarterly Data
	Nov07	Feb08	May08	Jun16	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Interest Expense	Get a 7-Day Free Trial															-0.10	-0.13	-	-0.31	-0.47

Predictive Technology Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.90 Mil.

Predictive Technology Group (OTCPK:PRED) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Predictive Technology Group's Interest Expense for the three months ended in Mar. 2021 was $-0.47 Mil. Its Operating Income for the three months ended in Mar. 2021 was $-3.23 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2021 was $3.33 Mil.

Predictive Technology Group's Interest Coverage for the quarter that ended in Mar. 2021 is calculated as

Predictive Technology Group did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Predictive Technology Group (Predictive Technology Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Predictive Technology Group Inc (OTCPK:PRED) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109

Website

https://www.predtechgroup.com

Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.